Vittavat Termglinchan
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Biomedical Engineering
- Cellular and Molecular Neuroscience top 10%
- Co-authors
- Joseph C. WuIoannis KarakikesMohamed AmeenNing‐Yi ShaoJared M. ChurkoHaodi WuM SnyderPraveen Shukla
- Topics
- CRISPR and Genetic Engineering (7 papers)Pluripotent Stem Cells Research (6 papers)Congenital heart defects research (5 papers)
- Partner nations
- United StatesGermanyThailand
In The Last Decade
Vittavat Termglinchan
15 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 777
- Cardiology and Cardiovascular Medicine 289
- Surgery 205
- Biomedical Engineering 189
- Cellular and Molecular Neuroscience 175
Countries citing papers authored by Vittavat Termglinchan
This map shows the geographic impact of Vittavat Termglinchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittavat Termglinchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittavat Termglinchan more than expected).
Fields of papers citing papers by Vittavat Termglinchan
This network shows the impact of papers produced by Vittavat Termglinchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittavat Termglinchan. The network helps show where Vittavat Termglinchan may publish in the future.
Co-authorship network of co-authors of Vittavat Termglinchan
This figure shows the co-authorship network connecting the top 25 collaborators of Vittavat Termglinchan. A scholar is included among the top collaborators of Vittavat Termglinchan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittavat Termglinchan. Vittavat Termglinchan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 94 | |
| 3 | 111 | |
| 4 | 38 | |
| 5 | 53 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 53 | |
| 9 | 129 | |
| 10 | 3 | |
| 11 | 116 | |
| 12 | 47 | |
| 13 | 342 | |
| 14 | 19 | |
| 15 | 4 |
About Vittavat Termglinchan
Vittavat Termglinchan is a scholar working on Molecular Biology, Human-Computer Interaction and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), Pluripotent Stem Cells Research (6 papers) and Congenital heart defects research (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (289 citations), Molecular Biology (777 citations) and Cellular and Molecular Neuroscience (175 citations). Vittavat Termglinchan has collaborated with scholars based in United States, Germany and Thailand. Frequent co-authors include Joseph C. Wu, Ioannis Karakikes, Mohamed Ameen, Ning‐Yi Shao, Jared M. Churko, Haodi Wu, M Snyder, Praveen Shukla, Kazuki Kodo and Sebastian Diecke. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Cell Biology and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.